Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions – A case study with itraconazole

Lipinski, 2002, Poor aqueous solubility – an industry wide problem in drug discovery, Am. Pharm. Rev., 5, 82 Rabinow, 2004, Nanosuspensions in drug delivery, Nat. Rev. Drug Discov., 3, 785, 10.1038/nrd1494 Müller, 2006, Manufacturing of nanoparticles by milling and homogenization techniques, vol. 159, 21 Kesisoglou, 2007, Nanosizing – oral formulation development and biopharmaceutical evaluation, Adv. Drug Deliv. Rev., 59, 631, 10.1016/j.addr.2007.05.003 Patravale, 2004, Nanosuspensions: a promising drug delivery strategy, J. Pharm. Pharmacol., 56, 827, 10.1211/0022357023691 Vergote, 2001, An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen, Int. J. Pharm., 219, 81, 10.1016/S0378-5173(01)00628-7 Möschwitzer, 2006, Spray coated pellets as carrier system for mucoadhesive drug nanocrystals, Eur. J. Pharm. Biopharm., 62, 282, 10.1016/j.ejpb.2005.09.005 Van Eerdenbrugh, 2007, Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling, Int. J. Pharm., 338, 198, 10.1016/j.ijpharm.2007.02.005 Lee, 2003, Drug nano- and microparticles processed into solid dosage forms: physical properties, J. Pharm. Sci., 92, 2057, 10.1002/jps.10471 Konan, 2002, Preparation and characterization of sterile and freeze dried sub-200nm nanoparticles, Int. J. Pharm., 233, 239, 10.1016/S0378-5173(01)00944-9 Mouton, 2006, Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation, Antimicrob. Agents Chemother., 50, 4096, 10.1128/AAC.00630-06 Vaughn, 2006, Single dose and multiple dose studies of itraconazole nanoparticles, Eur. J. Pharm. Biopharm., 63, 95, 10.1016/j.ejpb.2006.01.006 Weller, 2003, Cellulose microcrystalline, 108 Scott, 1953, Determination of dextran with anthrone, Anal. Chem., 25, 1656, 10.1021/ac60083a023 Costa, 2001, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci., 13, 123, 10.1016/S0928-0987(01)00095-1 Langenbucher, 1972, Linearization of dissolution rate curves by the Weibull distribution, J. Pharm. Pharmacol., 24, 979, 10.1111/j.2042-7158.1972.tb08930.x Jackson, 1990, The melting behavior of organic materials confined in porous solids, J. Chem. Phys., 93, 9002, 10.1063/1.459240 Allison, 2000, Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis, Biochim. Biophys. Acta, 1468, 127, 10.1016/S0005-2736(00)00251-0 Hinrichs, 2006, The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying, Int. J. Pharm., 311, 237, 10.1016/j.ijpharm.2005.12.032 Engstrom, 2008, Formation of stable submicron protein particles by thin film freezing, Pharm. Res., 25, 1334, 10.1007/s11095-008-9540-4 Lee, 2006, Critical freezing rate in freeze drying nanocrystal dispersions, J. Control. Release, 111, 185, 10.1016/j.jconrel.2005.12.003